Turnstone Biologics Acquires Novel Cell Therapy Platform

By Admin

January 20, 2021

Newsletters Hospital News

Facebook

Twitter

NEW YORK–(BUSINESS WIRE)–Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio
Source Read More

First Name *

Email *

Last Name *

Country *

Lists

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics

Industry News February 26, 2021

BeiGene Announces Closing of Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan

Industry News February 26, 2021

SYLVANT® (siltuximab) Recommended by the National Comprehensive Cancer Network® (NCCN®) as the Preferred Treatment Option for Patients with Idiopathic Multicentric Castleman Disease (iMCD) regardless...

Industry News February 26, 2021

Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies

Industry News February 26, 2021

Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty...

Look Who’s On the Move! February 26, 2021

Turnstone Biologics Acquires Novel Cell Therapy Platform

Recent Articles

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics

BeiGene Announces Closing of Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan

SYLVANT® (siltuximab) Recommended by the National Comprehensive Cancer Network® (NCCN®) as the Preferred Treatment Option for Patients with Idiopathic Multicentric Castleman Disease (iMCD) regardless...

Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies

Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty...